Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Human Normal Immunoglobulin and Anti-D Immunoglobulin:
Period of framework agreement: 1 July 2021 to 31 December 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be no more than 48 months
No supplier information available.